Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Northern Bitcoin AG    NB2   DE000A0SMU87

NORTHERN BITCOIN AG

(NB2)
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
05/20/2019 05/21/2019 05/22/2019 05/23/2019 05/24/2019 Date
20.6(c) 20.2(c) 19.4(c) 19.5(c) 20 Last
8 029 1 921 7 3 984 310 Volume
+7.29% -1.94% -3.96% +0.52% +2.56% Change
More quotes
Company
Biosilu Healthcare AG, formerly Amp Biosimilars AG, is a Germany-based biopharmaceutical company. The Company focuses on the development and commercialization of specialty biopharmaceuticals for patients in Asian regions. 
More about the company
Latest news on NORTHERN BITCOIN AG
2018NORTHERN BITCOIN AG : Dirk ströer buys large share package
EQ
2018NORTHERN BITCOIN : Agrees comprehensive strategic cooperation with rawpool - lau..
EQ
2018NORTHERN BITCOIN : And rawpool agree on comprehensive strategic cooperation in t..
EQ
2018NORTHERN BITCOIN AG : Commencement of trading on frankfurt stock exchange includ..
EQ
More news
Sector news : Bio Therapeutic Drugs
05/21Global chemical firms urged to source responsibly after lethal China blast - ..
RE
05/15GILEAD SCIENCES : Novartis gets approval to sell Kymriah in Japan for $306,000
RE
05/13REGENERON PHARMACEUTICALS : Says FDA Approves Eylea Injection for All Diabetic R..
DJ
05/10PATRICK THOMAS : Biotech Industry Woos Talent With Top Pay -- WSJ
DJ
05/09PATRICK THOMAS : Biotech Is Place to Be for Top Salaries
DJ
More sector news : Bio Therapeutic Drugs
Chart NORTHERN BITCOIN AG
Duration : Period :
Northern Bitcoin AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NORTHERN BITCOIN AG
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
 
Mean consensus
Number of Analysts 0
Average target price 35,5 €
Spread / Average Target 82%
Managers
NameTitle
Mathis Schultz Chief Executive Officer
Stefan Elsser Chairman-Supervisory Board
Moritz F. Jäger Chief Technology Officer
Bernd Hartmann Member-Supervisory Board
Simon Jules Nebel Vice Chairman-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
NORTHERN BITCOIN AG5.41%162
GILEAD SCIENCES7.39%84 558
VERTEX PHARMACEUTICALS4.41%44 148
REGENERON PHARMACEUTICALS-15.59%34 482
GENMAB12.69%11 076
SAREPTA THERAPEUTICS INC8.36%9 019